At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
NeuroStar TMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
In Brief
A clinical study evaluating NeuroStar TMS for Major Depressive Disorder. Completed, enrolled 67 participants across 6 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy of scheduled maintenance Transcranial Magnetic Stimulation (TMS) treatment compared to on-demand TMS treatment for symptomatic worsening in patients who have shown a clinical response to acute TMS treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedAug 2011
Primary CompletionSep 2013
Study CompletionJul 2014
TodayJul 2026
First PostedAug 11, 2011
Enrollment StartAug 1, 2011
Primary CompletionSep 1, 2013
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.9 years ago
Interventions
NeuroStar TMSdevice
NeuroStar TMS treatmant - 120% of Observed MT, 10 pulses per second, 4 second on-time, 26 second off-time, 75 trains, 3,000 total pulses/sessions for 6 days. 3 treatments in taper week 1, 2 treatments in taper week 2 and 1 treatment in taper week 3.